West Lafayette, IN, United States of America

Angel Enriquez

This inventor holds 1 USPTO granted patent. Top assignee: Purdue Research Foundation. Active years: 2026.


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Angel Enriquez: Innovator in Cancer Treatment Technologies

Introduction

Angel Enriquez is a notable inventor based in West Lafayette, IN (US). He has made significant contributions to the field of cancer treatment through his innovative patent. His work focuses on enhancing the accuracy of cancer treatment screening methods.

Latest Patents

Angel Enriquez holds a patent for a "High-throughput magnetic actuation platform for cancer treatment screening." This invention describes cell-culture platforms that can impart cyclic strain on a biologically relevant culture substrate. The systems and methods of this invention provide a more accurate model of physiological strain and forces compared to earlier technologies. Additionally, the systems enable high-throughput experimentation in standard culturing equipment while utilizing a 3D physiologically relevant environment. He has 1 patent to his name.

Career Highlights

Angel is associated with the Purdue Research Foundation, where he continues to develop and refine his innovative ideas. His work is pivotal in advancing cancer treatment methodologies, making significant strides in the medical field.

Collaborations

Angel collaborates with talented individuals such as Hyowon Lee and Hyunsu Park. Their combined expertise contributes to the success of their projects and enhances the research environment at Purdue Research Foundation.

Conclusion

Angel Enriquez is a dedicated inventor whose work in cancer treatment technologies is making a meaningful impact. His innovative approaches and collaborations are paving the way for advancements in medical research and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…